BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27933606)

  • 1. Relaxin-like peptides in male reproduction - a human perspective.
    Ivell R; Agoulnik AI; Anand-Ivell R
    Br J Pharmacol; 2017 May; 174(10):990-1001. PubMed ID: 27933606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin family peptides: structure-activity relationship studies.
    Patil NA; Rosengren KJ; Separovic F; Wade JD; Bathgate RAD; Hossain MA
    Br J Pharmacol; 2017 May; 174(10):950-961. PubMed ID: 27922185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin and related peptides in male reproduction.
    Agoulnik AI
    Adv Exp Med Biol; 2007; 612():49-64. PubMed ID: 18161481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.
    Ferlin A; De Toni L; Sandri M; Foresta C
    Br J Pharmacol; 2017 May; 174(10):1015-1024. PubMed ID: 27059798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the reproductive cycle and early pregnancy by relaxin family peptides.
    Anand-Ivell R; Ivell R
    Mol Cell Endocrinol; 2014 Jan; 382(1):472-479. PubMed ID: 23994019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in the understanding of relaxin family peptides and their receptors.
    Summers RJ
    Br J Pharmacol; 2017 May; 174(10):915-920. PubMed ID: 28447360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
    Ma S; Smith CM; Blasiak A; Gundlach AL
    Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
    Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
    Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the signaling system in relaxin-family peptides.
    Hsu SY; Semyonov J; Park JI; Chang CL
    Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the relaxin-like peptide family: from neuropeptide to reproduction.
    Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():530-3. PubMed ID: 15956756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology.
    Ivell R; Anand-Ivell R
    Hum Reprod Update; 2018 Nov; 24(6):639-651. PubMed ID: 30204868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular actions of relaxin: nitric oxide and beyond.
    Leo CH; Jelinic M; Ng HH; Marshall SA; Novak J; Tare M; Conrad KP; Parry LJ
    Br J Pharmacol; 2017 May; 174(10):1002-1014. PubMed ID: 27590257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin family peptides in the male reproductive system--a critical appraisal.
    Ivell R; Kotula-Balak M; Glynn D; Heng K; Anand-Ivell R
    Mol Hum Reprod; 2011 Feb; 17(2):71-84. PubMed ID: 20952422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Role of INSL3 in the Fetal Testis.
    Ivell R; Mamsen LS; Andersen CY; Anand-Ivell R
    Front Endocrinol (Lausanne); 2022; 13():868313. PubMed ID: 35464060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
    Agoulnik AI; Agoulnik IU; Hu X; Marugan J
    Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.
    Kumar JR; Rajkumar R; Jayakody T; Marwari S; Hong JM; Ma S; Gundlach AL; Lai MKP; Dawe GS
    Br J Pharmacol; 2017 May; 174(10):1061-1076. PubMed ID: 27597467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actions of relaxin on the human cardiovascular system.
    Sarwar M; Du XJ; Dschietzig TB; Summers RJ
    Br J Pharmacol; 2017 May; 174(10):933-949. PubMed ID: 27239943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.